RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Filing todayOr, if they see they're getting close, various large mgmt salaries can be deferred or cut. They can control the quarterly EBITDA via expenses primarily. Sales are what they are. I would guess some expenses they may want to characterize as one-off, non-operational and would be part of that "adjustment" to EBITDA. I would guess pay raises and bonuses are flat to down and there will still be some modest cost cutting we don't hear about in order to assure the EBITDA target is hit with a safety margin. You could also bump up the price of the drugs a bit. There's plenty of levers and I"m sure they're modeling it out a few quarters all the time until they can pay off the loan.